BJ044

N/A

Report date: 2026/04/17 13:42:20

Base Information

Drug NameBJ044
Drug Alias NameRecombinant ulinastatin(Baopharma)重组乌司他丁（宝济药业）BJ044BJ-044
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsSystemic Inflammatory Response SyndromePancreatitisSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShanghai Bao Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Bao Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsSystemic Inflammatory Response SyndromePancreatitisSepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A